Comparison of efficacy of oral ivermectin and topical permethrin 5% in the treatment of scabies
Keywords:
Scabies, oral ivermectin, permethrin, efficacy, safety, side effectsAbstract
Background Scabies an ectoparasitic infection caused in humans by the sarcoptes scabiei var.hominis.Ivermectin, an antiparasitic agent effective against a variety of ectoparasites and endoparasites . Permethrin an insecticide, applied topically kills the mite and its eggs, although patients may still experience some itching for several weeks. Objective: To compare the efficacy of oral ivermectin and topical permethrin 5% in treatment of scabies. Methadology : It was a randomized controlled trial conducted at Dermatology Department; Sir Gangaram Hospital Lahore / Fatima Jinnah Medical University Lahore. Sixty enrolled patients after informed consent were divided in 2 groups i.e. group-A and group-B. In group-A ,cases were treated with Tab ivermectin orally in dose of 200mcg/kg at day 0 and in group-B all cases were treated with topical permethrin 5% at day 0.The lesions were examined and compared with baseline clinical grading and itch grading scores .The cured patients were provided antihistamines for further 1 week if itching is moderate to severe.Efficacy was determined after one week of tretment. Results: Mean age in patients who recieved Permethrin 5 % was 41.67 ± 10.35 years and those received Ivermectine mean age was 39.67 ± 12.38 years. In Permethrin 5% group, 22(73.3%) cases showed efficacy and Ivermectine group 8(26.7%) cases showed efficacy (p-value < 0.05). Permethrin (5%) remained more efficacious. Conclusion: Scabies can be treated with permethrin 5% to achieve higher cure, by doing so we can improve patient’s quality of life. Keywords: Scabies, oral ivermectin, permethrin, efficacy, safety, side effectsReferences
Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2021;118(41):695-704. doi:10.3238/arztebl.m2021.0296
Zhang W, Zhang Y, Luo L, et al. Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017. Emerg Microbes Infect. 2020;9(1):813-6. doi:10.1080/22221751.2020.1754136
Ahmad HM, Abdel-Azim ES, Abdel-Aziz RT. Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies. Dermatol Ther. 2016;29(1):58-63.
Seetan K, Rashdan Y, Alsharei A, et al. Impact of socio-demographic factors on knowledge, attitude and practices toward scabies among syrian refugees in Jordan: A prospective cross sectional study. Ann Med Surg (Lond). 2021;69:102738.
Thompson R, Westbury S, Slape D. Paediatrics: how to manage scabies. Drugs Context. 2021;10:2020-12-3.
doi:10.7573/dic.2020-12-3
Engelman, D., Yoshizumi, J., Hay, RJ et al. The 2020 international alliance for the control of scabies consensus criteria for the diagnosis of scabies. Br J Dermatol. 2020 183(5):808-20.
Welch E, Romani L, Whitfeld MJ. Recent advances in understanding and treating scabies. Fac Rev. 2021;10:28.
doi:10.12703/r/10-28
Rosumeck S, Nast A, Dressler C. Ivermectin and permethrin for treating scabies. Cochrane Database Syst Rev. 2018;4(4):CD012994. doi:10.1002/14651858.CD012994
Sharma R, Singal A. Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study. Indian J Dermatol Venereolog Leprolog. 2011;77(5):581-6.
Ranjkesh MR, Naghili B, Goldust M, Rezaee E. The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies. Ann Parasitol. 2013;59(4):189-94.
Goldust M, Rezaee E, Hemayat S. Treatment of scabies: Comparison of permethrin 5% versus ivermectin. J Dermatol. 2012;39(6):545-7.
Chhaiya SB, Patel VJ, Dave JN, Mehta DS, Shah HA. Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies. Indian J Dermatol Venereol Leprol. 2012;78(5):605.
Mushtaq A, Khurshid K, Pal SS. Comparison of efficacy and safety of oral ivermectin with topical permethrin in treatment of scabies. J Pak Med Assoc. 2010;20(4):227-31.
Scheinfeld N. Controlling scabies in institutional settings. Am J Clin Dermatol. 2004;5(1):31-7.
Albakri L, Goldman RD. Permethrin for scabies in children. Can Fam Physician. 2010;56(10):1005-6.
Chouela E, Abeldaño A, Pellerano G, Hernández MI. Diagnosis and treatment of scabies. Am J Clin Dermatol. 2002;3(1):9-18.
